|
|
Predicting long-term cognitive outcomes and Alzheimer’s disease and related dementias after major noncardiac surgery for older adults |
| 1R01AG079263-01 |
|
NIA |
2022 |
|
|
Sleep apnea treatment and risk for cognitive decline and Alzheimers disease |
| 1R01AG079391-01 |
|
NIA |
2022 |
|
|
The role of sex in GABAergic-mediated, Alzheimer’s disease-related episodic memory impairments from mid to late life |
| 1R01AG079512-01 |
|
NIA |
2022 |
|
|
Deep brain stimulation of the Nucleus Basalis of Meynert: the role of stimulation parameters in neurogenesis and cognitive recovery |
| 1R03AG075637-01 |
|
NIA |
2022 |
|
|
Trajectories of Frailty and Cognitive Impairment in Older Adults |
| 1R03AG078933-01 |
|
NIA |
2022 |
|
|
Prefrontal neural modulation to restore cognitive deficits in an Alzheimers Disease rat model |
| 1R21AG072355-01A1 |
|
NIA |
2022 |
|
|
Genetic risk for trajectories of cognitive decline and progression to dementia among Mexican Americans and non-Hispanic whites |
| 1R21AG075791-01A1 |
|
NIA |
2022 |
|
|
Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment |
| 1R21AG077153-01 |
|
NIA |
2022 |
|
|
Development and characterization of EEG signature of cognitive fluctuations in Lewy body dementia |
| 1R21AG077469-01 |
|
NIA |
2022 |
|
|
Blood DNA Methylation Biomarkers of Alzheimer’s Disease and Postoperative Neurocognitive Disorder |
| 1R21AG077633-01 |
|
NIA |
2022 |
